Intracavitary radiotherapy boosting for nasopharynx cancer

The British Journal of Radiology
N J SlevinN K Gupta

Abstract

Intracavitary radiotherapy is conceptually an attractive method of boosting dose to nasopharynx cancer whilst sparing sensitive normal tissues. A high dose rate (HDR) microselectron can be used to deliver a brachytherapy boost conveniently, safely, comfortably and effectively. Following external radiotherapy a single outpatient treatment has been given to patients using the remote afterloading system of sources placed in modified paediatric endotracheal tubes. This has been associated with good primary control and no evidence of serious morbidity in eight patients. The main limitation of this method is restriction of its utilization to small volume primary disease.

References

Jan 1, 1988·Acta Oncologica·H R WithersB Maciejewski
Feb 1, 1981·International Journal of Radiation Oncology, Biology, Physics·J E MarksW F Blank
Apr 1, 1981·International Journal of Radiation Oncology, Biology, Physics·J B MesicH Goepfert

❮ Previous
Next ❯

Citations

Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Tracy NgAnthony M Berson
Apr 5, 2005·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S RiveraP Maingon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.